iTeos Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
iTeos Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • iTeos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $7.07M, a 1.67% decline year-over-year.
  • iTeos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $29.9M, a 10.8% increase year-over-year.
  • iTeos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $29.9M, a 10.8% increase from 2023.
  • iTeos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $27M, a 25.3% increase from 2022.
  • iTeos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $21.6M, a 56.3% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $29.9M +$2.92M +10.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $27M +$5.46M +25.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $21.6M +$7.77M +56.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $13.8M +$9.5M +221% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $4.29M +$3.48M +431% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $809K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.